These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7598535)
1. Distribution of 1,25-dihydroxyvitamin D3[22-oxa] in vivo receptor binding in adult and developing skin. Stumpf WE; Koike N; Hayakawa N; Tokuda K; Nishimiya K; Hirate J; Okazaki A; Kumaki K Arch Dermatol Res; 1995; 287(3-4):294-303. PubMed ID: 7598535 [TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 and 22-oxa-1,25-dihydroxyvitamin D3 in vivo nuclear receptor binding in developing bone during endochondral and intramembranous ossification. Stumpf WE; Koike N; Hayakawa N; Tokuda K; Nishimiya K; Tsuchiya Y; Hirate J; Okazaki A; Kumaki K Histochemistry; 1994 Sep; 102(3):183-94. PubMed ID: 7868361 [TBL] [Abstract][Full Text] [Related]
3. Topographical and developmental studies on target sites of 1,25 (OH)2 vitamin D3 in skin. Stumpf WE; Clark SA; Sar M; DeLuca HF Cell Tissue Res; 1984; 238(3):489-96. PubMed ID: 6098372 [TBL] [Abstract][Full Text] [Related]
4. In vivo dose-related receptor binding of the vitamin D analogue [3H]-1,25-dihydroxy-22-oxavitamin D3 (OCT) in rat parathyroid, kidney distal and proximal tubules, duodenum, and skin, studied by quantitative receptor autoradiography. Koike N; Hayakawa N; Kumaki K; Stumpf WE J Histochem Cytochem; 1998 Dec; 46(12):1351-8. PubMed ID: 9815276 [TBL] [Abstract][Full Text] [Related]
5. Sustained osteoblast nuclear receptor binding of converted 1alpha, 25-dihydroxyvitamin D3 after administration of 3H-1alpha-hydroxyvitamin D3: a combined receptor autoradiography and radioassay time course study with comparison to 3H-1alpha, 25-dihydroxyvitamin D3. Koike N; Ichikawa F; Nishii Y; Stumpf WE Calcif Tissue Int; 1998 Nov; 63(5):391-5. PubMed ID: 9799823 [TBL] [Abstract][Full Text] [Related]
6. 22-Oxacalcitriol: dissection of 1,25(OH)2D3 receptor-mediated and Ca2+ entry-stimulating pathways. Farach-Carson MC; Abe J; Nishii Y; Khoury R; Wright GC; Norman AW Am J Physiol; 1993 Nov; 265(5 Pt 2):F705-11. PubMed ID: 8238551 [TBL] [Abstract][Full Text] [Related]
7. In vivo time-course of receptor binding in the parathyroid gland of the vitamin D analogue [(3)H]1,25-dihydroxy-22-oxavitamin D(3) compared with [(3)H]1,25-dihydroxyvitamin D(3), determined by micro-autoradiography. Koike N; Hayakawa N; Tokuda K; Nishimiya K; Saito K; Stumpf WE Nephrol Dial Transplant; 2002; 17 Suppl 10():53-7. PubMed ID: 12386270 [TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 (soltriol) nuclear receptors in abdominal scent gland and skin of Siberian hamster (Phodopus sungorus) localized by autoradiography and immunohistochemistry. Stumpf WE; Pérez-Delgado MM; Li L; Bidmon HJ; Tuohimaa P Histochemistry; 1993 Aug; 100(2):115-9. PubMed ID: 8244763 [TBL] [Abstract][Full Text] [Related]
9. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells. Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745 [TBL] [Abstract][Full Text] [Related]
10. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes. Matsumoto K; Azuma Y; Kiyoki M; Okumura H; Hashimoto K; Yoshikawa K Biochim Biophys Acta; 1991 May; 1092(3):311-8. PubMed ID: 1646640 [TBL] [Abstract][Full Text] [Related]
11. The binding properties, with blood proteins, and tissue distribution of 22-oxa-1 alpha,25-dihydroxyvitamin D3, a noncalcemic analogue of 1 alpha, 25-dihydroxyvitamin D3, in rats. Kobayashi T; Tsugawa N; Okano T; Masuda S; Takeuchi A; Kubodera N; Nishii Y J Biochem; 1994 Mar; 115(3):373-80. PubMed ID: 8056745 [TBL] [Abstract][Full Text] [Related]
12. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Skowronski RJ; Peehl DM; Feldman D Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193 [TBL] [Abstract][Full Text] [Related]
13. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine. Brown AJ; Finch J; Grieff M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E Endocrinology; 1993 Sep; 133(3):1158-64. PubMed ID: 8396012 [TBL] [Abstract][Full Text] [Related]
14. In vivo microautoradiography of [3H]1,24(OH)2D3 (tacalcitol) following topical application to normal rats and in vitro metabolism in human keratinocytes. Ohta T; Okabe K; Azuma Y; Kiyoki M Arch Dermatol Res; 1996 Apr; 288(4):188-96. PubMed ID: 8967791 [TBL] [Abstract][Full Text] [Related]
15. Demonstration and characterization of 1,25-dihydroxyvitamin D3 receptors in basal cells of epidermis of neonatal and adult mice. Merke J; Schwittay D; Fürstenberger G; Gross M; Marks F; Ritz E Calcif Tissue Int; 1985 May; 37(3):257-67. PubMed ID: 2990643 [TBL] [Abstract][Full Text] [Related]
16. Effects of two new vitamin D3 derivatives, 22-oxa-1 alpha-25-dihydroxyvitamin D3 (OCT) and 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture. Sato K; Nishii Y; Woodiel FN; Raisz LG Bone; 1993; 14(1):47-51. PubMed ID: 8443002 [TBL] [Abstract][Full Text] [Related]
17. Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes. Matsumoto K; Hashimoto K; Kiyoki M; Yamamoto M; Yoshikawa K J Dermatol; 1990 Feb; 17(2):97-103. PubMed ID: 2158504 [TBL] [Abstract][Full Text] [Related]
18. Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells. Schroeder NJ; Burrin JM; Noonan K; Makin HL; Cunningham J Nephron Physiol; 2003; 94(4):p62-73. PubMed ID: 12972708 [TBL] [Abstract][Full Text] [Related]
19. 22-Oxacalcitriol, a noncalcemic analogue of calcitriol, suppresses both cell proliferation and parathyroid hormone-related peptide gene expression in human T cell lymphotrophic virus, type I-infected T cells. Inoue D; Matsumoto T; Ogata E; Ikeda K J Biol Chem; 1993 Aug; 268(22):16730-6. PubMed ID: 8393873 [TBL] [Abstract][Full Text] [Related]
20. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3. Griffin JE; Zerwekh JE J Clin Invest; 1983 Oct; 72(4):1190-9. PubMed ID: 6313754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]